Expertise in
4
conditions

Joaquin M. Lopez

Madrid, MD, ES 
Expertise in
4
conditions
Madrid, MD, ES 

Overview

Joaquin Lopez practices practicing medicine in Madrid, Spain.

Mr. Lopez is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Agranulocytosis, Leukemia, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Madrid, MD, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, GSK3174998, Feladilimab, Nirogacestat, Dostarlimab, Isatuximab
Study Phase: Phase 1/Phase 2
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies With Isocitrate Dehydrogenase (IDH) Mutations
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies With Isocitrate Dehydrogenase (IDH) Mutations
Enrollment Status: Terminated
Publish Date: January 29, 2026
Intervention Type: Drug
Study Drug: HMPL-306
Study Phase: Phase 1
A Multicenter, Prospective, Non-randomized, Phase I-II Trial to Assess the Efficacy and Safety of the Combination of Oral Quizartinib and the FLAG-IDA Chemotherapy Regimen in First Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Patients
A Multicenter, Prospective, Non-randomized, Phase I-II Trial to Assess the Efficacy and Safety of the Combination of Oral Quizartinib and the FLAG-IDA Chemotherapy Regimen in First Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Patients
Enrollment Status: Unknown
Publish Date: March 14, 2022
Intervention Type: Drug
Study Drugs: Quizartinib, Fludarabine, Cytarabine, Idarubicin, Granulocyte Colony-Stimulating Factor
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

8 Total Publications

Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting.
Journal: HemaSphere
Published: October 26, 2023

Frequently Asked Questions about Joaquin M. Lopez

Is Joaquin M. Lopez a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Joaquin M. Lopez is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Joaquin M. Lopez participate in research or clinical trials?

Yes. Joaquin M. Lopez has published 8 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Joaquin M. Lopez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lopez's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile